Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer
Clinical trial NCT01471106 · COMPLETED
Trial details
- NCT number
- NCT01471106
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-21
- Primary completion
- 2024-01-31
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.